Comparison of Peripheral Glucose Uptake After Oral Glucose Loading and a Mixed Meal
Overview
Affiliations
Forearm glucose uptake (FGU) and other metabolic responses were studied in six normal men for three hours after a 75-g oral glucose load and a mixed meal containing 75 g carbohydrate. After the meal the rise in arterial glucose levels was considerably less than that following the oral glucose load but the overall insulin responses from 0 to 180 minutes were not statistically different. Although the initial rise in FGU was more gradual after the meal, the subsequent elevation was more sustained and, at the termination of the study, exceeded significantly that seen after the oral glucose load. The rise in GIP levels during the first hour was similar after the meal and the oral glucose load, but thereafter concentrations following the oral glucose load fell while those after the meal continued to rise. When the incremental area (delta) is used as the index of response, the results show that while the glucose response (delta G) after the meal (19.1 +/- 5.3 units) was only 26% of that after oral glucose loading (72.7 +/- 7.0 units), the corresponding increase in FGU (delta FGU) reached 62% (55.0 +/- 12.8 units after the meal, 89.2 +/- 20.0 units after the oral glucose load). Thus, the increase in peripheral glucose uptake relative to the glycemic response (delta FGU/delta G) was significantly greater after the meal than following the oral glucose load alone (P less than 0.05). In conclusion, relative to the rise in arterial glucose levels, peripheral glucose uptake is greater after a meal than after glucose loading with an equivalent carbohydrate challenge. Furthermore, the present data support previous studies emphasizing the failure of GIP alone to explain the entero insular axis.
Zeng W, Qi W, Mu J, Wei Y, Yang L, Zhang Q Sci Rep. 2019; 9(1):2049.
PMID: 30765727 PMC: 6375942. DOI: 10.1038/s41598-018-38425-2.
Snook L, Nelson E, Dyck D, Wright D, Holloway G Am J Physiol Regul Integr Comp Physiol. 2015; 309(3):R295-303.
PMID: 26041107 PMC: 4525324. DOI: 10.1152/ajpregu.00003.2015.
Clinical pharmacokinetics and pharmacodynamics of vildagliptin.
He Y Clin Pharmacokinet. 2012; 51(3):147-62.
PMID: 22339447 DOI: 10.2165/11598080-000000000-00000.
Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets.
Zhou J, Livak M, Bernier M, Muller D, Carlson O, Elahi D Am J Physiol Endocrinol Metab. 2007; 293(2):E538-47.
PMID: 17505054 PMC: 2640485. DOI: 10.1152/ajpendo.00070.2007.
The physiological basis of insulin treatment--clinical aspects.
Waldhausl W Diabetologia. 1986; 29(12):837-49.
PMID: 3552811 DOI: 10.1007/BF00870138.